Hydrops MRI Accurately Differentiates Meniere Disease, Vestibular Migraine
By Elana Gotkine HealthDay Reporter
MONDAY, June 23, 2025 -- The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance imaging (MRI) accurately diagnoses Meniere disease (MD) and vestibular migraine (VM), according to a study published online May 13 in Frontiers in Neurology.
Anja Bernaerts, M.D., from ZAS Hospitals in Antwerp, Belgium, and colleagues conducted a prospective study involving 31 patients who underwent MRI: (15 with MD or probable MD and 16 with VM or probable VM) to examine the effectiveness of delayed postgadolinium three-dimensional sampling perfection with application-optimized contrasts using different flip angle evolution fluid-attenuated inversion recovery sequence to differentiate between MD and VM.
The researchers found that none of the patients with VM showed signs of CEH, VEH, or increased perilymphatic enhancement (PLE). Only two patients had normal CEH, one had normal VEH, and six had equal PLE in both ears in the MD group. Using both CEH and VEH, the logistic regression analysis correctly predicted all cases of MD and VM; 100 percent diagnostic accuracy was achieved for both of the conditions. Misclassifications resulted from use of only CEH, VEH, or PLE as diagnostic criteria; two, one, and six patients were incorrectly classified as having VM based on CEH, VEH, and PLE, respectively.
"We conclude that, since CEH, VEH, and asymmetrical PLE are not found in VM patients, hydrops MRI can effectively facilitate the differential diagnosis between VM and MD when applied in the appropriate clinical setting," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
AAP Updates Screening Guidance for Child Mental Health, Behavioral Problems
MONDAY, Aug. 25, 2025 -- In a clinical report issued by the American Academy of Pediatrics and published online Aug. 25 in Pediatrics, updated recommendations are presented for...
Discordance Seen Between Care Goals, Treatment Intent in Advanced Cancer
MONDAY, Aug. 25, 2025 -- More patients with advanced cancer report that their treatment discordantly focuses on longevity over comfort than patients with other illnesses...
Apitegromab Improves Motor Function in Spinal Muscular Atrophy
MONDAY, Aug. 25, 2025 -- For patients with nonambulatory type 2 or type 3 spinal muscular atrophy, apitegromab, a monoclonal antibody that inhibits myostatin activation, improves...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.